Search Results - "Ekstein, Tali"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
  2. 2

    Clinical and laboratory genetic counselor attitudes on the reporting of variants of uncertain significance for multigene cancer panels by Chang, Emmeline Y., Solomon, Ilana, Culver, Julie O., Gorman, Nicholas, Comeaux, Jacob G., Lerman, Caryn, Quinn, Emily A., Ekstein, Tali

    Published in Journal of genetic counseling (01-06-2023)
    “…Research suggests variants of uncertain significance (VUSs) present a variety of challenges for genetic counselors (GCs), nongenetics clinicians, and patients…”
    Get full text
    Journal Article
  3. 3

    Unexpected germline mutations in a pan-cancer analysis including sarcoma, renal, and other cancers by Yang, Shan, Michalski, Scott T., Holle, Jennifer, Ekstein, Tali, O'Leary, Erin, Pardo, Carolina, Heidari, Nastaran, Anderson, Michael, Ouyang, Karen, Nussbaum, Robert L., Lincoln, Stephen E, Esplin, Edward D.

    Published in Journal of clinical oncology (20-05-2017)
    “…Abstract only 1584 Background: Multi-gene testing for cancer predisposition is increasingly utilized in clinical care. Although the diagnostic yield and…”
    Get full text
    Journal Article
  4. 4

    Autosomal recessive MFN2-related Charcot-Marie-Tooth disease with diaphragmatic weakness: Case report and literature review by Tan, Christopher A., Rabideau, Marina, Blevins, Amy, Westbrook, Marjorie Jody, Ekstein, Tali, Nykamp, Keith, Deucher, Anne, Harper, Amy, Demmer, Laurie

    “…Pathogenic variants in the mitofusin 2 gene (MFN2) are the most common cause of autosomal dominant Charcot‐Marie‐Tooth (CMT2) disease, which is typically…”
    Get full text
    Journal Article
  5. 5

    Abstract P4-12-09: Low-level constitutional mosaicism of a de novo BRCA1 gene mutation by Friedman, Eitan, Efrat, Noa, Soussan-Gutman, Lior, Dvir, Addie, Kaplan, Yulia, Ekstein, Tali, Nykamp, Keith, Powers, Martin, Rabideau, Marina, Topper, Scott

    Published in Cancer research (Chicago, Ill.) (01-05-2015)
    “…Abstract Background: Germline mutations in the BRCA1 and BRCA2 genes detected in some high-risk breast/ovarian families are used to estimate cancer risk, plan…”
    Get full text
    Journal Article
  6. 6